Want to see FR:ALVIO full AI Analyst Report?
Valerio Therapeutics (ALVIO) Revenue
Valerio Therapeutics Revenue
Valerio Therapeutics had a revenue of 3.10M in the quarter ending Jun 30, 2026, with 26.77%. This bring the company's revenue in the last twelve months to 5.55M, Increased 115.66%. In the fiscal year ending Dec 31, 2025, Valerio Therapeutics had annual revenue of 2.57M with 43.50% growth.
- Revenue (ttm)
- 5.55M
- Revenue Growth
- 203.22%
- P/S Ratio
- 104.79
- Revenue/Employee
- EUR 62,756
- Employees
- 41
- Market Cap
- EUR 269.62M
Revenue Chart
Valerio Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.57M | 780.00K | 43.50% |
| Jun 30, 2025 | 1.79M | -7.00K | -0.39% |
| Dec 31, 2023 | 1.80M | 357.00K | 24.74% |
| Dec 31, 2022 | 1.44M | -2.62M | -64.48% |
| Dec 31, 2021 | 4.06M | 2.29M | 128.72% |
| Dec 31, 2020 | 1.78M | -2.51M | -58.58% |
| Dec 31, 2019 | 4.29M | -1.84M | -30.01% |
| Dec 31, 2018 | 6.13M | -3.38M | -35.54% |
| Dec 31, 2017 | 9.51M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.